Pharmacotherapy considerations in elderly adults

Southern Medical Journal

Volumn 105, Issue 8, 2012, Pages 437-445

  Wooten, James M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

elderly adults; medication; pharmacokinetics; pharmacology

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CYTOCHROME P450; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INTESTINE CONTRACTION STIMULATING AGENT; LISINOPRIL; LORAZEPAM; MORPHINE; MUSCLE RELAXANT AGENT; NAPROXEN; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREDNISONE; PROPRANOLOL; TRAMADOL; UNINDEXED DRUG; WARFARIN;

AMNESIA; ANTICHOLINERGIC SYNDROME; BALANCE IMPAIRMENT; BLADDER DISEASE; BLEEDING; BLOOD PRESSURE; BLURRED VISION; CLOSED ANGLE GLAUCOMA; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; CONSTIPATION; CREATININE CLEARANCE; DEHYDRATION; DELIRIUM; DEMENTIA; DIARRHEA; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG INTERACTION; DRUG PROTEIN BINDING; ELDERLY CARE; ELECTROLYTE DISTURBANCE; FALLING; FIRST PASS EFFECT; FRACTURE; GAIT DISORDER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HEALTH LITERACY; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPOTENSION; KIDNEY DISEASE; LIVER METABOLISM; MEDICAL DECISION MAKING; MENTAL HEALTH; MOTOR DYSFUNCTION; NAUSEA; ORTHOSTATIC HYPOTENSION; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; POLYPHARMACY; PRACTICE GUIDELINE; QT PROLONGATION; REVIEW; SEDATION; SIDE EFFECT; SWEATING; URINARY DYSFUNCTION; URINARY HESITANCY; URINE INCONTINENCE; URINE RETENTION; VOMITING; XEROSTOMIA;

AGE FACTORS; AGED; DRUG INTERACTIONS; DRUG THERAPY; HUMANS; MEDICATION ADHERENCE; MEDICATION ERRORS; MEDICATION SYSTEMS; PATIENT CARE PLANNING; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; POLYPHARMACY;

EID: 84864865440     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31825fed90     Document Type: Review

References (36)

1. TurnheimK. Drug therapy in the elderly. Exp Gerontol 2004;39:1731-1738. (Pubitemid 39576143)
2. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003;78:1564-1577. (Pubitemid 37475642)
3. Shrestha LB. CRS report for Congress. Life expectancy in the United States. http://aging.senate.gov/crs/aging1.pdf. Accessed February 13, 2012.
4. Williams CM. Using medications appropriately in older adults. Am Fam Phys 2002;66:1917-1924. (Pubitemid 36061540)
5. Wooten J, Galavis J. Polypharmacy: keeping the elderly safe. RN 2005; 68:44-51.
6. Brazeau S. Polypharmacy and the elderly. http://www.stacommunications. com/journals/cme/images/cmepdf/august01/polypharmacyapvd.pdf. Accessed January 20, 2012.
7. Drug therapy considerations in older adults. Health Notes 2003;1:5-53.
8. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56:163-184. (Pubitemid 38720828)
9. Chaurasia RN, Singh AK, Gambhir IS. Rational drug therapy in elderly. J Indian Acad Geriatr 2005;2:82-88.
10. Roehl B, Talati A, Parks S. Medication prescribing for older adults. Ann Long-Term Care 2006;14:33-39. (Pubitemid 43927068)
11. Petrone K, Katz P. Approaches to appropriate drug prescribing for the older adult. Prim Care Clin Office Pract 2005;32:755-775. (Pubitemid 41242371)
12. American Society of Consultant Pharmacists. ASCP fact sheet. https://www.ascp.com/articles/about-ascp/ascp-fact-sheet. Accessed January 18, 2012.
13. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007;21:217-230. (Pubitemid 46804936)
14. Hutchison LC, O'Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Prac 2007;20:4-12. (Pubitemid 47164037)
15. Miller SW. Therapeutic drug monitoring in the geriatric patient. In: Murphy JE, ed. Clinical Pharmacokinetics. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007: chap 23.
16. Ferrario CG. Geropharmacology: a primer for advanced practice acute care and critical care nurses, part I. AACN Adv Crit Care 2008;19:23-37.
17. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004;57:6-14. (Pubitemid 38067945)
18. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. Pharmacokinetics, pharmacodynamics, and drug disposition. In: Davis KL, Charney D, Coyle JT, et al, eds. Neuropsychopharmacology: The Fifth Generation of Progress. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002:507-524.
19. Kapadia A,Wynn D, Salzman B. Potential adverse effects of proton pump inhibitors in the elderly. Clin Geriatr 2010;18:24-31.
20. Richardson MM. Precision versus approximation: the trade off in assessing kidney function and drug dosing. Pharmacotherapy 2010;30: 758-761.
21. Nyman HA, Dowling TC, Hudson JQ, et al. Comparative evaluation of the Cockcroft-Gault equation and the modification of diet in renal disease (MDRD) study equation for drug dosing. Pharmacotherapy 2011; 31:1130-1144.
22. Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005;22:375-392. (Pubitemid 41003068)
23. Routledge PA, O'Mahony MS,WoodhouseKW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004;57:121-126. (Pubitemid 38223523)
24. Gray CL, Gardner C. Adverse drug events in the elderly: an ongoing problem. J Manag Care Pharm 2009;15:568-571.
25. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Phys 2005;72:1723-1734. (Pubitemid 41633282)
26. Amarapurkar DN. Prescribing medications in patients with decompensated liver cirrhosis. Int J Hepatol 2011;11:1-5.
27. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007;5:263-303. (Pubitemid 350048507)
28. Wang L. Epidemiology and prevention of adverse drug reactions in the elderly. J Geriatr Cardiol 2005;2:248-253.
29. Mendes-Nett RS, Silva CQ, Oliveira Filho AD, et al. Assessment of drug interactions in elderly patients of a family health care unit in Aracaju (Brazil): a pilot study. Afr J Pharm Pharmacol 2011;5:812-818.
30. Grattagliano I, Portincasa P, D'Ambrosio G, et al. Avoiding drug interactions: here's help. J Fam Pract 2010;59:322-329.
31. Lin P. Drug interactions and polypharmacy in the elderly. Can Alzheimers Dis Rev 2003;6:10-14.
32. Steinman MA, Handler SM, Gurwitz JH, et al. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 2011;59:1513-1520.
33. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;10: 1532-1541.
34. Baker DW, Wolf MS, Feinglass J, et al. Health literacy and mortality among elderly persons. Arch Intern Med 2007;167:1503-1509. (Pubitemid 47124180)
35. Weiss BD. Health Literacy and Patient Safety: Help Patients Understand: A Manual for Clinicians. Chicago: American Medical Association 2007.
36. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011;171:1013-1019.